In a new consensus statement, the European Society of Cardiology has declared vaccinations for common infections to be a ...

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...

The stocks listed here each increased their dividend payments by more than 10% recently. When you think of a great dividend ...

Shares in drug companies such as Eli Lilly dropped from their session highs Tuesday afternoon after President Donald Trump said U.S. tariffs on imported pharmaceuticals could be as high as 200%.

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Eli Lilly and Johnson & Johnson, PPH’s largest holdings, are facing unique challenges, impacting the ETF’s overall ...

The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...

Buying $1000 In LLY: If an investor had bought $1000 of LLY stock 10 years ago, it would be worth $8,701.53 today based on a price of $771.99 for LLY at the time of writing.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

President Donald Trump threatened Tuesday to levy up to 200% tariffs on drugs imported into the U.S. "very soon." ...

Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...